CORDIS
EU research results

CORDIS

English EN

Personalised nutrition of low-birth-weight infants

Project information

Grant agreement ID: 879228

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 June 2021

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 2 377 937,50

  • EU contribution

    € 1 664 556

Coordinated by:

TELLSPEC LTD

United Kingdom

Objective

Each year 500,000 preterm babies are born in Europe out of 15-million worldwide. They often have poor health, with a severe lifetime impact on their quality of life and that of their families. Pre-term birth is a leading cause of lifelong disabilities with high societal economic costs. Inadequate nutrition is the major reason for preterm infants’ ill health. To grow as they would in utero, preterm infants need more nutrition than is provided by their mother’s milk, so the milk needs to be fortified to avoid undernourishment. However, the fortification typically done in Neonatal Intensive Care Units (NICUs) does not take into account the individual differences in the human milk’s composition and the infant’s nutritional needs, which vary with age and weight.
To address this issue, Tellspec has developed Preemie, the first rapid, portable, affordable, and easy-to-use milk testing system calibrated with human milk, that automatically calculates the fortification needed, to reduce the workload and human errors. Preemie also uses blockchain technology to trace the origin and confirm the authenticity of the donor’s milk. An inexpensive portable and rapid analyser such as Preemie would disrupt the existing market by allowing NICUs and milk banks to scan all donor milk and automatically suggest fortification to be done based on each infant's individual needs, resulting in optimal health.
In this project Tellspec will commercialise Preemie, by tailoring the software to the market and validate it in collaboration with a European hospital and a milk bank, by obtaining the medical certification needed to go to market, and by implementing advertising, sales promotions and marketing activities.
The funds raised will enable Tellspec to enlarge its customer base, expand the current team of people, set up high-volume distribution capacity in Europe, and consolidate the business strategy to pave the way for future VC investments.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

TELLSPEC LTD

Address

83 Cambridge Street
Sw1v 4ps London

United Kingdom

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 1 664 556

Project information

Grant agreement ID: 879228

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 June 2021

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 2 377 937,50

  • EU contribution

    € 1 664 556

Coordinated by:

TELLSPEC LTD

United Kingdom